Literature DB >> 33420056

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.

Nighat Noureen1,2, Shaofang Wu3, Yingli Lv1, Juechen Yang1, W K Alfred Yung3, Jonathan Gelfond2, Xiaojing Wang1,2, Dimpy Koul3, Andrew Ludlow4, Siyuan Zheng5,6.   

Abstract

Active telomerase is essential for stem cells and most cancers to maintain telomeres. The enzymatic activity of telomerase is related but not equivalent to the expression of TERT, the catalytic subunit of the complex. Here we show that telomerase enzymatic activity can be robustly estimated from the expression of a 13-gene signature. We demonstrate the validity of the expression-based approach, named EXTEND, using cell lines, cancer samples, and non-neoplastic samples. When applied to over 9,000 tumors and single cells, we find a strong correlation between telomerase activity and cancer stemness. This correlation is largely driven by a small population of proliferating cancer cells that exhibits both high telomerase activity and cancer stemness. This study establishes a computational framework for quantifying telomerase enzymatic activity and provides new insights into the relationships among telomerase, cancer proliferation, and stemness.

Entities:  

Year:  2021        PMID: 33420056     DOI: 10.1038/s41467-020-20474-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  79 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 2.  Hallmarks of telomeres in ageing research.

Authors:  J W Shay; W E Wright
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Telomerase is processive.

Authors:  C W Greider
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

Review 4.  Telomeres and telomerase in cancer.

Authors:  Steven E Artandi; Ronald A DePinho
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

Review 5.  Telomeres in cancer: tumour suppression and genome instability.

Authors:  John Maciejowski; Titia de Lange
Journal:  Nat Rev Mol Cell Biol       Date:  2017-01-18       Impact factor: 94.444

6.  Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.

Authors:  Kunitoshi Chiba; Franziska K Lorbeer; A Hunter Shain; David T McSwiggen; Eva Schruf; Areum Oh; Jekwan Ryu; Xavier Darzacq; Boris C Bastian; Dirk Hockemeyer
Journal:  Science       Date:  2017-08-17       Impact factor: 47.728

Review 7.  Telomeres: cancer to human aging.

Authors:  Sheila A Stewart; Robert A Weinberg
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

8.  The RNA component of human telomerase.

Authors:  J Feng; W D Funk; S S Wang; S L Weinrich; A A Avilion; C P Chiu; R R Adams; E Chang; R C Allsopp; J Yu
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

9.  Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues.

Authors:  A A Avilion; M A Piatyszek; J Gupta; J W Shay; S Bacchetti; C W Greider
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

Review 10.  Shelterin: the protein complex that shapes and safeguards human telomeres.

Authors:  Titia de Lange
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 12.890

View more
  9 in total

1.  Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data.

Authors:  Nighat Noureen; Zhenqing Ye; Yidong Chen; Xiaojing Wang; Siyuan Zheng
Journal:  Elife       Date:  2022-02-25       Impact factor: 8.140

Review 2.  T-Cell Factors as Transcriptional Inhibitors: Activities and Regulations in Vertebrate Head Development.

Authors:  Johnny Bou-Rouphael; Béatrice C Durand
Journal:  Front Cell Dev Biol       Date:  2021-11-24

3.  H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.

Authors:  Mi Zhang; Wei Zhao; Shanshan Liu; Haichuan Liu; Liang Liu; Qiling Peng; Chengyou Du; Ning Jiang
Journal:  Pharmgenomics Pers Med       Date:  2021-10-19

4.  Pan-Cancer Analyses Identify the CTC1-STN1-TEN1 Complex as a Protective Factor and Predictive Biomarker for Immune Checkpoint Blockade in Cancer.

Authors:  Lishuai Wang; Tengfei Ma; Weijin Liu; Heping Li; Zhenhua Luo; Xuyang Feng
Journal:  Front Genet       Date:  2022-03-16       Impact factor: 4.599

Review 5.  Telomere Targeting Approaches in Cancer: Beyond Length Maintenance.

Authors:  Eleonora Vertecchi; Angela Rizzo; Erica Salvati
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 6.  Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair.

Authors:  Ken-Ichi Yoshioka; Rika Kusumoto-Matsuo; Yusuke Matsuno; Masamichi Ishiai
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  The telomere maintenance mechanism spectrum and its dynamics in gliomas.

Authors:  Sojin Kim; Tamrin Chowdhury; Hyeon Jong Yu; Jee Ye Kahng; Chae Eun Lee; Seung Ah Choi; Kyung-Min Kim; Ho Kang; Joo Ho Lee; Soon-Tae Lee; Jae-Kyung Won; Kyung Hyun Kim; Min-Sung Kim; Ji Yeoun Lee; Jin Wook Kim; Yong-Hwy Kim; Tae Min Kim; Seung Hong Choi; Ji Hoon Phi; Young-Kyoung Shin; Ja-Lok Ku; Sungyoung Lee; Hongseok Yun; Hwajin Lee; Dokyoung Kim; Kyoungmi Kim; Junho K Hur; Sung-Hye Park; Seung-Ki Kim; Chul-Kee Park
Journal:  Genome Med       Date:  2022-08-11       Impact factor: 15.266

8.  Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.

Authors:  Yoko Matsuda; Taro Yamashita; Juanjuan Ye; Mami Yasukawa; Keiko Yamakawa; Yuri Mukai; Mitsuhiro Machitani; Yataro Daigo; Yohei Miyagi; Tomoyuki Yokose; Takashi Oshima; Hiroyuki Ito; Soichiro Morinaga; Takeshi Kishida; Toshinari Minamoto; Shinji Yamada; Junko Takei; Mika K Kaneko; Motohiro Kojima; Shuichi Kaneko; Tsutomu Masaki; Masahiro Hirata; Reiji Haba; Keiichi Kontani; Nobuhiro Kanaji; Nobuyuki Miyatake; Keiichi Okano; Yukinari Kato; Kenkichi Masutomi
Journal:  J Pathol       Date:  2022-03-23       Impact factor: 9.883

9.  High-efficiency c-Myc-mediated induction of functional hepatoblasts from the human umbilical cord mesenchymal stem cells.

Authors:  Jie Deng; Kai Luo; Pengchao Xu; Qingyuan Jiang; Yuan Wang; Yunqi Yao; Xiaolei Chen; Fuyi Cheng; Dan Xie; Hongxin Deng
Journal:  Stem Cell Res Ther       Date:  2021-07-02       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.